Skip to main content

Online Only

FDA Updates

Keytruda Received FDA Approval for Adjuvant Treatment of Non–Small-Cell Lung Cancer

FDA Updates

Tukysa, in Combination with Trastuzumab, Now FDA Approved for HER2-Positive Unresectable or Metastatic Colorectal Cancer

FDA Updates

Brukinsa Now FDA Approved for Patients with CLL or SLL

FDA Updates

Tecentriq Now FDA Approved for Treatment of Alveolar Soft-Part Sarcoma

ASCO Highlights

PD-1 Inhibition with Dostarlimab Led to Remission in All Patients with Mismatch Repair-Deficient Rectal Cancer

ASCO Highlights

Black Patients with Cancer and COVID-19 More Likely Than White Patients to Have Therapy Disruptions

ASCO Highlights

Trastuzumab Deruxtecan a New Standard for Patients with HER2-Low Metastatic Breast Cancer

ASCO Highlights

Patients Aged ≥55 Years with Luminal A Breast Cancer Can Safely Avoid Radiation

ASCO Highlights

ASCO Highlights Innovation as Key to Equitable Cancer Care

FDA Updates

FDA Issues New Warning for Copiktra About Increased Risks for Serious Side Effects and Mortality

1
2
3
4

Page 1 of 4
Results 1 - 10 of 36